Funder
TETFund
Taiwan Bio-Development Foundation and The MOE (Taiwan) Technologies Incubation Scholarship
Wellcome Trust
Publisher
Springer Science and Business Media LLC
Reference87 articles.
1. Tzeng, Y. L. & Stephens, D. S. Epidemiology and pathogenesis of Neisseria meningitidis. Microb. Infect. 2, 687–700 (2000).
2. Andrews, S. M. & Pollard, A. J. A vaccine against serogroup B Neisseria meningitidis: Dealing with uncertainty. Lancet Infect. Dis. 14, 426–434 (2014).
3. Finne, J., Leinonen, M. & Makela, P. H. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 2, 355–357 (1983).
4. Swartley, J. S. et al. Capsule switching of Neisseria meningitidis. Proc. Natl. Acad. Sci. USA 94, 271–276 (1997).
5. Boslego, J. et al. Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease. Vaccine 13, 821–829 (1995).
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献